Christine Lu‐Emerson

Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival

Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar et al. · Proceedings of the National Academy of Sciences · 2016 · 356 citations · Full text

Life Sciences, Immunology, Oncology +17

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

Tracy T. Batchelor, Elizabeth R. Gerstner, Kyrre E. Emblem et al. · Proceedings of the National Academy of Sciences · 2013 · 342 citations · Full text

Medicine, Oncology, Pharmacology +17

Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma

Christine Lu‐Emerson, Matija Snuderl, Nathaniel D. Kirkpatrick et al. · Neuro-Oncology · 2013 · 225 citations · Full text

Medicine, Oncology, Pathology +17

Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma

Christine Lu‐Emerson, Dan G. Duda, Kyrre E. Emblem et al. · Journal of Clinical Oncology · 2015 · 178 citations · Full text

Medicine, Oncology, Pharmacology +17

Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure

Christine Lu‐Emerson, Andrew D. Norden, Jan Drappatz et al. · Journal of Neuro-Oncology · 2010 · 64 citations

Medicine, Oncology, Medical Oncology +14